Summit Therapeutics to Test Cancer Drug Combination With AstraZeneca, Daiichi Sankyo

Summit Therapeutics announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo to test their cancer drug Datroway in combination with Summit's ivonescimab. The combination will be tested across multiple tumor types, including lung and breast cancers.